Case Report
Published on 04 Mar 2024
Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction
in Cancer Immunity and Immunotherapy
- 3,380 views
- 1 citation
Case Report
Published on 04 Mar 2024
in Cancer Immunity and Immunotherapy
Review
Published on 31 Oct 2023
in Cancer Immunity and Immunotherapy
Case Report
Published on 12 Mar 2025
in Gastroenterology
Original Research
Published on 28 Mar 2022
in Hematology
Systematic Review
Published on 16 Apr 2025
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 07 Mar 2023
in Cancer Immunity and Immunotherapy
Systematic Review
Published on 11 Nov 2022
in Cancer Immunity and Immunotherapy